Medicare Rx Agreement Nears; Bill Looks Good For Pharmaceutical Firms

The Medicare conference negotiators have agreed on a drug benefit design that includes a $5,000 catastrophic coverage cap

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet